Skin aging is primarily driven by declining collagen production (peaks at 25, declines ~1% per year after), reduced elastin synthesis, decreased cellular turnover, oxidative stress accumulation, and loss of the extracellular matrix scaffolding that gives youthful skin its firmness and elasticity.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is perhaps the most studied skin peptide. It occurs naturally in human plasma, saliva, and urine — acting as a master wound-healing and skin-renewal signal. Research shows GHK-Cu activates over 4,000 genes related to tissue remodeling and repair, stimulates collagen and elastin production, and powerfully reduces inflammation.
A 2015 analysis found GHK-Cu to be one of the most powerful known activators of skin repair genes — upregulating the same pathways involved in wound healing and collagen synthesis. Its anti-aging effects include measurable increases in skin thickness, firmness, and reduction in fine lines.
Systemic GH optimization complements topical and injectable peptide approaches — IGF-1 is a major driver of collagen production throughout the body. Patients on GH secretagogue protocols consistently report significant skin quality improvements alongside body composition benefits.